P. Davis

Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells.

J. Marks, A. Berchuck, A. Elbendary, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells

J. Marks, A. Berchuck, L. Havrilesky, 1994 .

Isolation and initial characterization of the BRCA2 promoter

P. Davis, J. Iglehart, A. Miron, 1999, Oncogene.

Transforming Growth Factor 131 Can Induce CIP1/WAF1 Expression Independent of the p53 Pathway

R. Bast, A. Berchuck, L. Havrilesky, 1994 .

BRCA1 expression is not directly responsive to estrogen

A. Futreal, P. Davis, J. Iglehart, 1997, Oncogene.

The Novel Vascular Disrupting Agent ANG501 Induces Cell Cycle Arrest and Enhances Endothelial Cell Sensitivity to Radiation

P. Davis, G. Dougherty, S. Dougherty, 2009 .

Complex response of breast epithelial cell lines to topoisomerase inhibitors.

W. Shaiu, P. Davis, J. Iglehart, 1998, Anticancer research.

BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

A. Berchuck, A. C. Evans, P. Davis, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.

G. Lozano, P. Davis, J. Iglehart, 1996, Oncogene.

Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.

M. Caruthers, P. Davis, J. Iglehart, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

R. Bast, A. Berchuck, L. Havrilesky, 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.